ĀÜĄņĀŅĀ×

Celeste Richardson is an accomplished leader in the field of immunology with extensive experience in research and development of cell therapies, particularly CAR T cell and engineered TCR T cell therapies. Currently serving as Senior Vice President of Immunology at Stylus Medicine, Celeste has held significant positions as Vice President of Research at 2seventy bio and Senior Vice President of Research at Catamaran Bio, Inc. Prior roles include Vice President of Cell Therapy at Obsidian Therapeutics and senior investigator roles at Novartis Institutes for BioMedical Research, where Celeste led global project teams and managed cross-functional collaborations. Celeste's academic credentials include a postdoctoral fellowship at Harvard Medical School and PhDs in Biochemistry and Molecular Biology from the University of Chicago.